Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early alzheimer disease pathology

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 7, 2012, Pages 654-664

  Kao, Patricia F ^a   Banigan, Meredith G ^d   Vanderburg, Charles R ^d   McKee, Ann C ^b,e   Polgar, Peter R ^c   Seshadri, Sudha ^b,e   Delalle, Ivana ^a,b,e  

^a Pathology and Laboratory Medicine   (United States)

^b Department of Neurology ^*  (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d The Harvard Center for Neurodegeneration & Repair   (United States)

^e FRAMINGHAM HEART STUDY   (United States)

Author keywords

Alzheimer disease; Brain reserve; Brain derived neurotrophic factor; Capzb2; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; PROTEIN CAPZ;

ACTIN FILAMENT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM MEMORY; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTIN CAPPING PROTEINS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMANS; LASER CAPTURE MICRODISSECTION; MALE; NEUROPSYCHOLOGICAL TESTS; RECEPTOR, TRKB; RNA, MESSENGER; SIGNAL TRANSDUCTION; SILVER STAINING; UP-REGULATION;

EID: 84862903771     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31825d06b7     Document Type: Article

References (53)

1. Seshadri S, Wolf PA, Beiser A, et al. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology 1997;49:1498-504 (Pubitemid 28015107)
2. Seshadri S, Wolf PA. Lifetime risk of stroke and dementia: Current concepts, and estimates from the Framingham Study. Lancet Neurol 2007;6:1106-14 (Pubitemid 350123607)
3. Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009;15:331-37
4. Phillips HS, Hains JM, Armanini M, et al. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991; 7:695-702
5. Connor B, Young D, Lawlor P, et al. Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res 1996;42:1-17 (Pubitemid 26345400)
6. Fujimura RK, Reiner T, Ma F, et al. Changes in the expression of genes associated with intraneuronal amyloid-beta and tau in Alzheimer's disease. J Alzheimers Dis 2010;19:97-109
7. Kao PF, Davis DA, Banigan MG, et al. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease. PLoS One 2010;5:e13337
8. Yan Q, Rosenfeld RD, Matheson CR, et al. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 1997;78:431-48 (Pubitemid 27170335)
9. Shetty AK, Rao MS, Hattiangady B, et al. Hippocampal neurotrophin levels after injury: Relationship to the age of the hippocampus at the time of injury. J Neurosci Res 2004;78:520-32 (Pubitemid 39536496)
10. Goutan E, Marti E, Ferrer I. BDNF, and full length and truncated TrkB expression in the hippocampus of the rat following kainic acid excitotoxic damage. Evidence of complex time-dependent and cell-specific responses. Brain Res Mol Brain Res 1998;59:154-64 (Pubitemid 28434498)
11. Avwenagha O, Campbell G, Bird MM. Distribution of GAP-43, beta-III tubulin and F-actin in developing and regenerating axons and their growth cones in vitro, following neurotrophin treatment. J Neurocytol 2003;32:1077-89 (Pubitemid 39004718)
12. Miyamoto Y, Yamauchi J, Tanoue A, et al. TrkB binds and tyrosinephosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology. Proc Natl Acad Sci USA 2006;103:10444-49 (Pubitemid 44051186)
13. Luo L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000;1:173-80
14. Li Y, Grupe A. Genetics of late-onset Alzheimer's disease: Progress and prospect. Pharmacogenomics 2007;8:1747-55
15. Nathan BP, Chang KC, Bellosta S, et al The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 1995;270:19791-99
16. Arendt T, Schindler C, Bruckner MK, et al Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele. J Neurosci 1997;17:516-29 (Pubitemid 27024565)
17. Davis DA, Wilson MH, Giraud J, et al Capzb2 interacts with beta-tubulin to regulate growth cone morphology and neurite outgrowth. PLoS Biol 2009;7:e1000208
18. Nelson TJ, Backlund PS Jr, Alkon DL. Hippocampal protein-protein interactions in spatial memory. Hippocampus 2004;14:46-57 (Pubitemid 38351171)
19. Linnarsson S, Bjorklund A, Ernfors P. Learning deficit in BDNF mutant mice. Eur J Neurosci 1997;9:2581-87 (Pubitemid 28082947)
20. Kitanishi T, Sakai J, Kojima S, et al Activity-dependent localization in spines of the F-actin capping protein CapZ screened in a rat model of dementia. Genes Cells 2010;15:737-47
21. Scheibel AB, Tomiyasu U. Dendritic sprouting in Alzheimer's presenile dementia. Exp Neurol 1978;60:1-8 (Pubitemid 8357532)
22. Scheibel AB. Dendritic changes in senile and presenile dementias. Res Publ Assoc Res Nerv Ment Dis 1979;57:107-24
23. McKee AC, Kowall NW, Kosik KS. Microtubular reorganization and dendritic growth response in Alzheimer's disease. Ann Neurol 1989;26: 652-59
24. Labelle C, Leclerc N. Exogenous BDNF, NT-3 and NT-4 differentially regulate neurite outgrowth in cultured hippocampal neurons. Brain Res Dev Brain Res 2000;123:1-11
25. Olde Rikkert MG, Tona KD, Janssen L, et al. Validity, reliability, and feasibility of clinical staging scales in dementia: A systematic review. Am J Alzheimers Dis Other Demen 2011;26:357-65
26. Braak H, Braak E. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging 1997;18:S85-88 (Pubitemid 27454703)
27. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44 (Pubitemid 14076461)
28. Farmer ME, White LR, Kittner SJ, et al. Neuropsychological test performance in Framingham: A descriptive study. Psychol Rep 1987;60: 1023-40
29. Au R, Seshadri S, Wolf PA, et al. New norms for a new generation: Cognitive performance in the Framingham offspring cohort. Exp Aging Res 2004;30:333-58 (Pubitemid 39238368)
30. Morris JC, Weintraub S, Chui HC, et al. The Uniform Data Set (UDS): Clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 2006;20:210-16 (Pubitemid 44900933)
31. Weintraub S, Salmon D, Mercaldo N, et al. The Alzheimer's Disease Centers' Uniform Data Set (UDS): The neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009;23:91-101
32. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811
33. Hachinski VC, Iliff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-37
34. Davis PB, White H, Price JL, et al. Retrospective postmortem dementia assessment. Validation of a new clinical interview to assist neuropathologic study. Arch Neurol 1991;48:613-17
35. Au R, Seshadri S, Knox K, et al. The Framingham Brain Donation Program: Neuropathology along the cognitive continuum [published online ahead of print April 2, 2012]. Curr Alzheimer Res
36. Durrenberger PF, Fernando S, Kashefi SN, et al. Effects of antemortem and postmortem variables on human brain mRNA quality: A BrainNet Europe study. J Neuropathol Exp Neurol 2010;69:70-81
37. Frank L, Ventimiglia R, Anderson K, et al. BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. Eur J Neurosci 1996;8:1220-30 (Pubitemid 26174647)
38. Riemenschneider M, Schwarz S, Wagenpfeil S, et al. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E epsilon4 allele. Mol Psychiatry 2002;7:782-85 (Pubitemid 34984956)
39. Lee J, Fukumoto H, Orne J, et al. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp Neurol 2005;194:91-96 (Pubitemid 40719746)
40. Forlenza OV, Diniz BS, Teixeira AL, et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 2010;11: 774-80
41. Egan MF, Kojima M, Callicott JH, et al. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257-69 (Pubitemid 36144114)
42. Antal A, Chaieb L, Moliadze V, et al. Brain-derived neurotrophic factor (BDNF) gene polymorphisms shape cortical plasticity in humans. Brain Stimul 2010;3:230-37
43. Tian F, Marini AM, Lipsky RH. NMDA receptor activation induces differential epigenetic modification of BDNF promoters in hippocampal neurons. Amino Acids 2010;38:1067-74
44. He DY, Neasta J, Ron D. Epigenetic regulation of BDNF expression via the scaffolding protein RACK1. J Biol Chem 2010;285:19043-50
45. Wu A, Ying Z, Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008;155:751-59
46. Nichol K, Deeny SP, Seif J, et al. Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement 2009; 5:287-94
47. Kuzumaki N, Ikegami D, Tamura R, et al. Hippocampal epigenetic modification at the brain-derived neurotrophic factor gene induced by an enriched environment. Hippocampus 2011;21:127-32
48. Larson EB, Wang L, Bowen JD, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006;144:73-81 (Pubitemid 46768225)
49. Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003;348:2508-16 (Pubitemid 36706538)
50. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:270-79
51. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:280-92
52. Peleg S, Sananbenesi F, Zovoilis A, et al. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010;328:753-56
53. Fischer A, Sananbenesi F, Wang X, et al. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007;447: 178-82 (Pubitemid 46763080)